You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Cloud startup Benchling just launched a new product to help life sciences companies make better ...
Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...
Sajith Wickramasekara started biotech R&D software company Benchling in his MIT dorm room. Now it's worth $850 million. Sajith Wickramasekara started working on an idea for a cloud-based Crispr design ...
During the COVID-19 pandemic, scientists around the world rushed to create vaccines for the virus using mRNA technology. The pandemic showed the importance of quickly developing new therapeutics for a ...
Life sciences-focused cloud startup Benchling has seen its business soar over the last few years due to the pandemic, and a renewed interest in biotech among investors. Now, just as it hits a ...
Sajith Wickramasekara co-founded Benchling to improve laboratory data collection and collaboration. Since its 2012 founding, the company has grown to a valuation of $6.1 billion. Wickramasekara will ...
Benchling today launched Benchling Automation, a hardware-agnostic system that connects lab instruments, automation systems, ...
Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run Benchling Biologics is the end-to-end platform for antibody R&D, giving teams the AI-ready ...
Climax Foods ramps up its ingredient discovery through its partnership with Benchling, an AI-driven data platform, which scours over 300,000 edible plant varieties to determine ingredients that offer ...
Benchling’s unicorn status didn’t come overnight. Some 10 years after its founding, the company is worth more than $6 billion, and the founder sees the company going public in the future. The ...
Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...
Benchling, a maker of software for the biotechnology industry, is valued at $6.1 billion after a funding round led by Altimeter Capital Management and new investor Franklin Templeton. The San ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results